Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.
Mínguez A, Conde I, Montón C, Gonzalez L, Pascual S, Antón MD, Palau A, Forés A, Gisbert C, Ojeda A, Girona E, Di Maira T, Berenguer M. Mínguez A, et al. Among authors: conde i. Dig Dis Sci. 2024 Mar 22. doi: 10.1007/s10620-024-08368-y. Online ahead of print. Dig Dis Sci. 2024. PMID: 38517562
Early versus late cardiac magnetic resonance in the diagnosis of MINOCA.
Conde IM, Salazar M, Pereira VH, Vieira C, Braga CG, Oliveira C. Conde IM, et al. Rev Port Cardiol. 2024 Mar 14:S0870-2551(24)00075-1. doi: 10.1016/j.repc.2023.12.010. Online ahead of print. Rev Port Cardiol. 2024. PMID: 38492801 Free article. English, Portuguese.
Multi-lumen coronary artery: The role of intracoronary imaging.
Mané F, Silva R, Conde I, Braga C, Costa J. Mané F, et al. Among authors: conde i. Cardiovasc Revasc Med. 2024 Feb 1:S1553-8389(24)00020-4. doi: 10.1016/j.carrev.2024.01.019. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 38326208 No abstract available.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy: The ARCADIA Randomized Clinical Trial.
Kamel H, Longstreth WT Jr, Tirschwell DL, Kronmal RA, Marshall RS, Broderick JP, Aragón García R, Plummer P, Sabagha N, Pauls Q, Cassarly C, Dillon CR, Di Tullio MR, Hod EA, Soliman EZ, Gladstone DJ, Healey JS, Sharma M, Chaturvedi S, Janis LS, Krishnaiah B, Nahab F, Kasner SE, Stanton RJ, Kleindorfer DO, Starr M, Winder TR, Clark WM, Miller BR, Elkind MSV; ARCADIA Investigators. Kamel H, et al. JAMA. 2024 Feb 20;331(7):573-581. doi: 10.1001/jama.2023.27188. JAMA. 2024. PMID: 38324415
Unveiling an Unusual Cause of Cardiac Tamponade.
Conde I, Salomé N, Sousa A, Quina C. Conde I, et al. Cureus. 2023 Dec 23;15(12):e50984. doi: 10.7759/cureus.50984. eCollection 2023 Dec. Cureus. 2023. PMID: 38259365 Free PMC article.
Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
Medina-Cáliz I, Sanabria-Cabrera J, Villanueva-Paz M, Aukštikalnė L, Stephens C, Robles-Díaz M, Pinazo-Bandera JM, García-Cortes M, Conde I, Soriano G, Bessone F, Hernandez N, Nunes V, Paraná R, Lucena MI, Andrade RJ, Niu H, Alvarez-Alvarez I. Medina-Cáliz I, et al. Among authors: conde i. Arch Toxicol. 2024 Jan;98(1):303-325. doi: 10.1007/s00204-023-03630-0. Epub 2023 Dec 5. Arch Toxicol. 2024. PMID: 38051367 Free PMC article.
Clinical presentation, causative drugs and outcome of patients with autoimmune features in two prospective DILI registries.
García-Cortés M, Ortega-Alonso A, Matilla-Cabello G, Medina-Cáliz I, Castiella A, Conde I, Bonilla-Toyos E, Pinazo-Bandera J, Hernández N, Tagle M, Nunes V, Parana R, Bessone F, Kaplowitz N, Lucena MI, Alvarez-Alvarez I, Robles-Díaz M, Andrade RJ. García-Cortés M, et al. Among authors: conde i. Liver Int. 2023 Aug;43(8):1749-1760. doi: 10.1111/liv.15623. Epub 2023 Jun 3. Liver Int. 2023. PMID: 37269163
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry. Díaz-González Á, et al. Among authors: conde i. Hepatology. 2023 Apr 1;77(4):1095-1105. doi: 10.1097/HEP.0000000000000018. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626622 Free article.
105 results